aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Numira Biosciences, founded to advance the field of disease research and drug discovery, specializes in providing virtual histology and imaging services. Their core mission is to enhance pre-clinical studies through advanced imaging techniques in animal models, thereby accelerating the development of new treatments. Numira's services are crucial for pharmaceutical companies and research institutions focused on understanding disease mechanisms and evaluating therapeutic efficacy.
The company has attracted notable investors and collaborators from the biotech and pharmaceutical sectors, contributing to its reputation as a leader in virtual histology. Key achievements include the successful implementation of their imaging technology in several high-profile drug discovery projects, significantly reducing the time and cost associated with pre-clinical trials. Numira Biosciences has made a substantial impact on the research community by providing detailed, non-invasive imaging solutions that improve the accuracy and efficiency of disease studies.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Imaging Services, Virtual Histology
Technology
AI, Machine Learning
Tags
Biotech, Healthtech
Model Types
Professional Services, Software
Revenue Type(s)
Recurring, Consulting
Geographic Exposure
Americas
When was Numira Biosciences founded?
Numira Biosciences was founded in 2005.
Where is Numira Biosciences’s headquarters located?
Numira Biosciences’s headquarters is located in Salt Lake City, US.
How many employees does Numira Biosciences have?
Numira Biosciences has 75 employees as of Feb 5, 2024.
How much has Numira Biosciences raised to-date?
As of July 05, 2023, Numira Biosciences has raised a total of $5.8M (USD) since Mar 7, 2013.
Add Comparison
Total Raised to Date
$5.8M
USD
Last Update Mar 7, 2013
Total Employees Over Time
75
As of Feb 2024
Numira Biosciences Address
560 Arapeen Drive
Suite 250
Salt Lake City,
84108
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts